US 12,195,773 B2 | PH20 Polypeptide Variants, Formulations and Uses Thereof | Ex Parte

US 12,195,773 B2

PH20 Polypeptide Variants, Formulations and Uses Thereof

Please sign up or log in to access the advanced features of
Ex Parte Enterprise.

General

US 12,195,773 B2

PH20 Polypeptide Variants, Formulations and Uses Thereof

Tech Center:

1600 Biotechnology and Organic Chemistry

Examiner:

AMELIA NICOLE DICKENS

Art Unit:

1645 Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology

Agent:

Morgan, Lewis & Bockius LLP

Inventors:

H. Michael SHEPARD; Robert James CONNOR; H. Michael SHEPARD; Robert James CONNOR

Assignee:

HALOZYME THERAPEUTICS, INC.

Priority:

--

Filed:

05/09/24

Granted:

01/14/25

Expiration:

12/30/31

Cooperative Patent Classification (CPC)

G01G01N2333/928G01NA61P43/00A61K2300/00A61PC12Q1/34C12Y302/01035C12N9/2474C12QC07K2319/30C07KY02A50/30Y02A

Analytics

Cases

Patent Assignments

Citations